Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Related Articles by Review for PubMed (Select 23171809)

1.

Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary.

Samardzija C, Quinn M, Findlay JK, Ahmed N.

J Ovarian Res. 2012 Nov 21;5(1):37. doi: 10.1186/1757-2215-5-37.

2.

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

Ahmed N, Abubaker K, Findlay J, Quinn M.

Curr Cancer Drug Targets. 2010 May;10(3):268-78. Review.

PMID:
20370691
3.

Ovarian cancer stem cells: a new target for cancer therapy.

Zhan Q, Wang C, Ngai S.

Biomed Res Int. 2013;2013:916819. doi: 10.1155/2013/916819. Epub 2013 Jan 30. Review.

4.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
5.

Role of cancer stem cells in spine tumors: review of current literature.

Hsu W, Mohyeldin A, Shah SR, Gokaslan ZL, Quinones-Hinojosa A.

Neurosurgery. 2012 Jul;71(1):117-25. doi: 10.1227/NEU.0b013e3182532e71. Review.

PMID:
22418583
6.

Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.

Bernhardt M, Galach M, Novak D, Utikal J.

Biotechnol J. 2012 Jun;7(6):810-21. doi: 10.1002/biot.201100347. Epub 2012 May 16. Review.

PMID:
22589234
7.

Human induced pluripotent stem cells--from mechanisms to clinical applications.

Drews K, Jozefczuk J, Prigione A, Adjaye J.

J Mol Med (Berl). 2012 Jul;90(7):735-45. doi: 10.1007/s00109-012-0913-0. Epub 2012 May 30. Review.

PMID:
22643868
8.

Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM.

J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. Review.

PMID:
18539958
9.

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

Dunning NL, Laversin SA, Miles AK, Rees RC.

Cancer Immunol Immunother. 2011 Aug;60(8):1181-93. doi: 10.1007/s00262-011-1065-8. Epub 2011 Jun 19. Review.

PMID:
21688178
10.

The stem cell identity of testicular cancer.

Clark AT.

Stem Cell Rev. 2007 Jan;3(1):49-59. Review.

PMID:
17873381
11.

Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals.

Chen SS, Michael A, Butler-Manuel SA.

Discov Med. 2012 Jan;13(68):7-17. Review.

12.

Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors.

Khalil MA, Hrabeta J, Cipro S, Stiborova M, Vicha A, Eckschlager T.

Neoplasma. 2012;59(6):737-46. doi: 10.4149/neo_2012_093. Review.

PMID:
22862175
13.

An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.

Safari M, Khoshnevisan A.

World J Stem Cells. 2014 Jan 26;6(1):53-64. doi: 10.4252/wjsc.v6.i1.53. Review.

14.

Cancer stem cells and novel targets for antitumor strategies.

Prud'homme GJ.

Curr Pharm Des. 2012;18(19):2838-49. Review.

PMID:
22390767
15.

Cancer stem cell epigenetics and chemoresistance.

Crea F, Danesi R, Farrar WL.

Epigenomics. 2009 Oct;1(1):63-79. doi: 10.2217/epi.09.4. Review.

PMID:
22122637
16.

Hypoxia and hypoxia inducible factors in cancer stem cell maintenance.

Li Z, Rich JN.

Curr Top Microbiol Immunol. 2010;345:21-30. doi: 10.1007/82_2010_75. Review.

PMID:
20582533
17.

Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.

Tomao F, Papa A, Strudel M, Rossi L, Lo Russo G, Benedetti Panici P, Ciabatta FR, Tomao S.

J Cancer. 2014 Mar 16;5(5):301-10. doi: 10.7150/jca.8610. eCollection 2014. Review.

18.

Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

Walters Haygood CL, Arend RC, Straughn JM, Buchsbaum DJ.

World J Stem Cells. 2014 Sep 26;6(4):441-7. doi: 10.4252/wjsc.v6.i4.441. Review.

19.

Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.

Hombach-Klonisch S, Natarajan S, Thanasupawat T, Medapati M, Pathak A, Ghavami S, Klonisch T.

Front Endocrinol (Lausanne). 2014 Mar 25;5:37. doi: 10.3389/fendo.2014.00037. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk